Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 18, 2006. The document serves as a report regarding special resolutions passed at the Company's Annual General Meeting (AGM) held on May 17, 2006.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is administrative in nature and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses solely on the submission of AGM resolutions to the UK Listing Authority.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It confirms that two copies of all resolutions passed under special business at the AGM have been submitted to the UK Listing Authority and are available for inspection at the Financial Services Authority in London.
Investor Verification Points
- Verify the specific content of the special resolutions passed at the May 17, 2006 AGM via the UK Listing Authority's Document Viewing Facility.
- Confirm that this filing is a procedural report and does not replace or update the company's financial results.